CYP2B6 Genotype Guided Dosing of Propofol Anesthesia in the Elderly Based on Nonparametric Population Pharmacokinetic Modeling and Simulations
Journal Title: International Journal of Clinical Pharmacology & Toxicology(IJCPT) - Year 2017, Vol 6, Issue 1
Abstract
Objective: The primary aim of this article is to test the hypothesis that nonparametric pharmacometric modeling will accurately identify CYP2B6 genotype subgroups based on data from a study that reported results based on parametric pharmacokinetics (PK). Methods: Propofol concentration-time data were originally reported in the Kansaku et al., 2011 publication. Nonparametric Nonlinear Mixed Effects Modeling (NLME) was conducted using the PMETRICS R package while population pharmacokinetic model parameters were estimated using a FORTRAN compiler. Finally, model-based dosing simulations were conducted in the MATLAB Simbiology. Results: A total of 51 patients were included in the final PK analysis. A two-compartment gamma multiplicative error model adequately described the propofol concentration-time data. The individual observed versus predicted R2=0.99 and R-squared=0.93 for the population model predictions. Neither the UGT1A9 nor the CYP2B6 G516T gene variants resulted in statistically significant PK parameter differences while the CYP2B6 A785G gene variants resulted in statistically significant differences for the elimination rate. Model-based dosing-simulations comparing patients with the CYP2B6 AA & AG genotypes to both GG genotypes and patients from a multicenter trial suggest a 50% decrease in propofol infusion dose, to 25mg/ kg/min, be made to result in approximately equivalent drug exposures. Conclusion: Based on the pharmacometric modeling and simulation, if no dosage adjustments are made for the elderly CYP2B6 AA and AG genotypes, a 250% higher propofol blood exposure will be evident within 1-hour from the start of the infusion. Thus, based on the pharmacokinetic model, genotyping elderly patients for the CYP2B6 AA and AG gene variants will decrease the total propofol blood exposure during anesthesia and sedation when an infusion dose adjustment is made to 25mg/kg/min.
Authors and Affiliations
Andy R. Eugene
Keywords
Related Articles
- EP ID EP324145
- DOI 10.19070/2167-910X-1700041
- Views 77
- Downloads 0
Efficacy and Safety of Angiotensin-Based Pharmacotherapy versus Conventional Therapy for the Management of Isolated Systolic Hypertension: A Meta-Analysis of Randomized Controlled Trials
The angiotensin (AT) system is highly implicated in the pathophysiology of isolated systolic hypertension (ISH). Consequently, this meta-analysis was designed to quantitatively review the efficacy and safety of angiotens...
Need for Pharmacogenomic Information Also for Generic Medications; Recommendation of the European Society of Pharmacogenomics and Theranostics (ESPT)
Need for Pharmacogenomic Information Also for Generic Medications; Recommendation of the European Society of Pharmacogenomics and Theranostics (ESPT)
Identifying Treatment Response of Sertraline in a Teenager with Selective Mutism using Electrophysiological Neuroimaging
Background: Selective Mutism is described as the inability to verbally express oneself in anxiety provoking social situations and may result in awkward social interactions in school-aged children. In this case-report we...
Iron Chelating and Antioxidant Activities and Cytotoxicity Effect of the Pistachio (Pistachio vera L.) hull and kernel Extracts in the A549, HT29 and MCF-7 Cancerous Cell lines
Synthetic iron-chelators have been considered for treatment of some clinical situations such as iron overloading and cancer. However, their side effects and incomplete effectiveness limit their usages. Natural products c...
PAR-2-Mediated Relaxation of Rectum is Impaired Following Bacillary Dysentery in Rat
Background: PAR-2 activation modifies the intestinal motility and takes part in gastrointestinal motility disturbances under intestinal infection or inflammation, but its role in the regulation of normal rectum motility...